BRIEF-Aurinia Pharmaceuticals releases additional 48-week data from AURA-LV study
April 20, 2017 at 17:19 PM EDT
* Aurinia releases additional 48-week data from the AURA-LV study during late-breaking session at the National Kidney Foundation 2017 spring clinical meetings